Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Discover brokers offering index funds, focusing on accessibility, fees, and customer experience to pick the best platform.
23,867 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Investors who bought the Global X Lithium & Battery Tech ETF last June are seeing a 125% return as lithium demand imp...
Strategy has restarted bitcoin purchases, acquiring 1,550 BTC for about $101 million and lifting its total BTC stash ...
When a company's top executive sells a large chunk of stock, investors take note. This article dives into Privia Heal...
Bitcoin, Ethereum, and XRP flashed potential buy signals after a wide market drop, according to on-chain analytics. A...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Rising coastal insurance costs are reshaping retirement plans as insurers reprice risk and pull back from high‑cost z...
Credit to Credo Technology stock rose on a strong earnings beat, but the path ahead hinges on demand for AI infrastru...
Bitcoin steadies near $62,000 as a major bitcoin demand drop sparks debate about whether the market is close to a cyc...
SpaceX's much-anticipated IPO is expected to deliver a first-day surge that could surpass historic records. Valued ar...
BlackRock has filed Form 8-A for a yield-bearing Bitcoin ETF, signaling a near-term launch window. Market commentary ...
As AI accelerates automation, broad-based learning helps young people adapt and manage money. This report explains wh...